Esperion Therapeutics, Inc. ($ESPR)
Filing Information
| Accession Number | 0001628280-26-048000 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 13, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
1,339,680
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jul 13, 2026 | Sale to Issuer | 705,410 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Jul 13, 2026 | Sale to Issuer | 200,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Jul 13, 2026 | Sale to Issuer | 213,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Jul 13, 2026 | Sale to Issuer | 221,270 | โ | โ | 0 | Direct | โ | View Details |